CDT Equity Inc. (CDT) P/E Ratio History
Historical price-to-earnings valuation from 2024 to 2024
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 4, 2026, CDT Equity Inc. (CDT) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.60 and trailing twelve-month earnings per share of $-0.50.
The current P/E is 100% below its 5-year average of 27747.5x. Over the past five years, CDT's P/E has ranged from a low of 471.1x to a high of 79500.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.3x, CDT trades at a 100% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 190.3x.
Relative to the broader market, CDT trades at a notable discount to the S&P 500 median P/E of 26.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CDT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Royalty and IP Monetization Vehicles peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 26.6 | - | -7% | |
| $2B | 6.7Lowest | 0.65Best | +817%Best | |
| $765M | 38.6 | - | -83% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q3 | Sun Sep 29 2024 00:00:00 GM | $1504.80 | $0.46 | 3271.3x | -88% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $12720.00 | $0.16 | 79500.0x | +187% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $44040.00 | $93.49 | 471.1x | -98% |
Average P/E for displayed period: 27747.5x
See CDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CDT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CDT vs AGIO
See how CDT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CDT stock overvalued or undervalued?
CDT current P/E: -0.0x. 5-year average P/E: 27747.5x. Percentile: N/A.
How does CDT's valuation compare to peers?
CDT Equity Inc. P/E of -0.0x compares to sector median of 23.3x. Sector comparison provides relative valuation context.
What is CDT's PEG ratio?
CDT PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2024-2024.